BridgeMD
New treatment option for Skin-to-skin Contact
Official title Skin-to-skin Contact in Healthy Term Infants
ClinicalTrials.gov ID: NCT06777524
What this study is testing
- What it's testing
- This is a prospective, double-blind, randomized controlled clinical trial study to investigate short- and long-term effects of mother-infant skin-to-skin contact in healthy term infants, in order to provide supporting data for emphasizing mother-infant skin contact and family-centered care in South Korea.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 72. Healthy volunteers may be eligible.
You may be able to join if
- Babies born at Korea University Anam Hospital
- Term infants (37 weeks or more)
- Infants with a birth weight of 2,500g or more
- Healthy infants with an Apgar score of 7 or higher at 5 minutes
- Mothers and infants without severe acute complications, such as requiring intensive care treatment immediately after delivery
You likely can't join if
- Preterm infants born at 37 weeks of less gestation
- Low birth weight infants weighing less than 2500g at birth
- Mothers under the age of 20
- Unmarried mothers
- Multiple pregnancies (twins or triplets)
- Parents do not consent to participation in the study
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 hour to 72 hours. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.